Sign In
Buy QTRX
$3.22
-0.270 (-7.74%)
At Close: Jun 23, 2026
Wall Street Analysts See a 54.88% Upside in Quanterix Corporation (QTRX): Can the Stock Really Move This High?
11:17am, Monday, 13'th Nov 2023
The mean of analysts' price targets for Quanterix Corporation (QTRX) points to a 54.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement
Quanterix Corporation (QTRX) Q3 2023 Earnings Call Transcript
03:15pm, Tuesday, 07'th Nov 2023
Quanterix Corporation (NASDAQ:QTRX ) Q3 2023 Earnings Conference Call November 7, 2023 8:30 AM ET Company Participants Ed Joyce - VP, IR Masoud Toloue - President and CEO Vandana Sriram - CFO Conferen
7 Stocks to Buy if You Anticipate a Hot November
05:30pm, Monday, 06'th Nov 2023
While enough evidence exists that justify a pessimistic view of the market – in particular, high inflation and high borrowing costs – it's also possible that a hot November could rejuvenate previo
Quanterix Corporation: Going For Three In A Row
01:45pm, Monday, 06'th Nov 2023
Today, we revisit Quanterix Corporation, a life sciences company that develops and markets digital immunoassay platforms. The company has posted much better than expected quarterly numbers over the pa
Quanterix Corporation (QTRX) Moves 7.2% Higher: Will This Strength Last?
11:17am, Thursday, 28'th Sep 2023
Quanterix Corporation (QTRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the
Quanterix: Advancing sNfL Reference Ranges In Pediatric Neurology
11:46am, Thursday, 24'th Aug 2023
Quanterix specializes in ultra-sensitive digital immunoassay platforms for early disease detection, potentially transforming disease management. The company's financials show promising growth, with to
Quanterix Corporation (QTRX) Reports Q2 Loss, Tops Revenue Estimates
09:09pm, Monday, 07'th Aug 2023
Quanterix Corporation (QTRX) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $0.67 per share a year ago.
Quanterix (QTRX) Advances in Alzheimer's Diagnosis With LucentAD
12:30pm, Monday, 10'th Jul 2023
Quanterix (QTRX) LucentAD biomarker blood test aims to assist healthcare providers in evaluating patients who show cognitive symptoms consistent with the early signs of AD.
Quanterix Corporation (QTRX) Surges 13.6%: Is This an Indication of Further Gains?
03:29am, Monday, 10'th Jul 2023
Quanterix Corporation (QTRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strengt
Quanterix to Participate in Fireside Chat at Goldman Sachs Annual Global Healthcare Conference
04:00pm, Wednesday, 07'th Jun 2023
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer
Quanterix Corporation (QTRX) Q1 2023 Earnings Call Transcript
06:47pm, Saturday, 13'th May 2023
Quanterix Corporation (NASDAQ:QTRX ) Q1 2023 Results Conference Call May 9, 2023 4:30 PM ET Company Participants Mike Doyle - CFO Masoud Toloue - President and CEO Conference Call Participants Alex Vu
Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates
06:20pm, Tuesday, 09'th May 2023
Quanterix Corporation (QTRX) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $0.49 per share a year ago.
Quanterix Corporation (QTRX) Soars 33.7%: Is Further Upside Left in the Stock?
01:41pm, Thursday, 04'th May 2023
Quanterix Corporation (QTRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strengt
Quanterix's First Quarter 2023 Earnings Conference Call
04:30pm, Tuesday, 02'nd May 2023
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced it will host a conference ca
Quanterix Corporation (QTRX) Reports Q4 Loss, Misses Revenue Estimates
11:17am, Monday, 06'th Mar 2023
Quanterix Corporation (QTRX) delivered earnings and revenue surprises of 5.66% and 1.28%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
